M1A.1691 Lead-induced chronic gout, unspecified knee, with tophus (tophi)

Name of the Condition

• Lead-Induced Chronic Gout, Unspecified Knee, With Tophus (Tophi)
• ICD Code: M1A.1691

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to persistent joint inflammation and uric acid crystal deposition in the knee. It is characterized by recurrent episodes of pain and swelling, with the knee being the specific site affected. Unlike acute gout, this condition persists over time and may involve tissue damage if untreated. The presence of tophi, which are chalky deposits of uric acid crystals, distinguishes this subtype.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

• Long-term lead exposure (occupational or environmental)
• Pre-existing hyperuricemia or gout history
• Male gender
• Middle-aged or older adults
• Impaired kidney function

Symptoms

• Recurrent joint pain, swelling, and tenderness in the affected knee
• Warmth or redness in the affected knee
• Limited mobility during flare-ups
• Presence of tophi (visible or palpable chalky deposits)
• Persistent discomfort between episodes

Diagnosis

Diagnosis combines clinical evaluation, lab tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis detects urate crystals. Imaging (X-ray, ultrasound) evaluates joint damage and tophi presence. Clinical correlation with lead exposure history is essential.

Treatment Options

• Medications such as non-steroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids to reduce inflammation
• Urate-lowering therapies (e.g., allopurinol) to prevent crystal formation
• Management of lead exposure to reduce ongoing risk
• Surgical removal of tophi if they cause functional impairment or pain

Prognosis and Follow-Up

Prognosis depends on early intervention and lead exposure control. Untreated cases may lead to joint deformity or chronic pain. Regular follow-up includes monitoring uric acid levels, joint function, and tophi progression. Long-term management focuses on preventing flare-ups and complications.

Complications

• Chronic joint damage or deformity
• Persistent pain or disability
• Increased risk of kidney stones or renal impairment
• Tophi-related skin breakdown or infection

Lifestyle & Prevention

• Avoid lead exposure through occupational or environmental safeguards
• Maintain a healthy weight and balanced diet to support uric acid metabolism
• Stay hydrated to promote uric acid excretion
• Limit alcohol and high-purine foods, which may exacerbate gout

When to Seek Professional Help

Seek care if experiencing severe knee pain, swelling, or redness, especially with a history of lead exposure. Prompt evaluation is needed for persistent symptoms or tophi development to prevent joint damage.

Tips for Medical Coders

Document the presence of tophi and specify the knee as the affected site. Ensure lead exposure history is clearly recorded, as it differentiates this condition from other gout subtypes. Use M1A.1691 only when tophi are present and the knee is the site, with no further specification of laterality.